FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Agop Bedikian

Research Profile

Disorders

Chemicals & Drugs

Procedures

Antineoplastic Combined Chemotherapy Protocols

Concepts & Ideas

Co-author Network

Publications

TOP 3
Gladys Alvarado; Roland Bassett; Agop Bedikian; Patrick Hwu; Wen-Jen Hwu; Kevin B Kim; Rahat Noor; Nicholas E Papadopoulos; Sapna Patel; Michael A Davies
Risk of intracranial hemorrhage with anticoagulation therapy in melanoma patients with brain metastases.
Richard W Joseph; Kevin Kim; Jeffrey E Lee; Ping Liu; Anthony Lucci; John D McMannis; Priscilla W Miller; Willem W Overwijk; Nicholas Papadopoulos; Vijay R Peddareddigari; Victor G Prieto; Agop Bedikian; Nebiyou B Bekele; Jeffrey E Gershenwald; Jade Homsi; Patrick Hwu; Wen-Jen Hwu; Merrick I Ross; Laszlo G Radvanyi
Impact of clinical and pathologic features on tumor-infiltrating lymphocyte expansion from surgically excised melanoma metastases for adoptive T-cell therapy.
Michael A Davies; Ping Liu; Susan McIntyre; Kevin B Kim; Nicholas Papadopoulos; Wen-Jen Hwu; Patrick Hwu; Agop Bedikian
Prognostic factors for survival in melanoma patients with brain metastases.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Agop Bedikian (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Gladys Alvarado; Roland Bassett; Agop Bedikian; Patrick Hwu; Wen-Jen Hwu; Kevin B Kim; Rahat Noor; Nicholas E Papadopoulos; Sapna Patel; Michael A Davies
Risk of intracranial hemorrhage with anticoagulation therapy in melanoma patients with brain metastases.
Melanoma research 2012;22(4):310-5.
2011: Richard W Joseph; Kevin Kim; Jeffrey E Lee; Ping Liu; Anthony Lucci; John D McMannis; Priscilla W Miller; Willem W Overwijk; Nicholas Papadopoulos; Vijay R Peddareddigari; Victor G Prieto; Agop Bedikian; Nebiyou B Bekele; Jeffrey E Gershenwald; Jade Homsi; Patrick Hwu; Wen-Jen Hwu; Merrick I Ross; Laszlo G Radvanyi
Impact of clinical and pathologic features on tumor-infiltrating lymphocyte expansion from surgically excised melanoma metastases for adoptive T-cell therapy.
Clinical cancer research : an official journal of the American Association for Cancer Research 2011;17(14):4882-91.
2011: Michael A Davies; Ping Liu; Susan McIntyre; Kevin B Kim; Nicholas Papadopoulos; Wen-Jen Hwu; Patrick Hwu; Agop Bedikian
Prognostic factors for survival in melanoma patients with brain metastases.
Cancer 2011;117(8):1687-96.
2011: Nathalie A Kolandjian; Sapna P Patel; Nicholas E Papadopoulos; Agop Bedikian
The left ventricle as the first site of uveal melanoma metastasis 13 years after treatment of the primary tumor.
Melanoma research 2011;21(2):160-3.
2011: Gladys C Alvarado; Nicholas E Papadopoulos; Wen-Jen Hwu; Agop Bedikian; Jade Homsi; Jeffrey N Myers; Yulia Bronstein; Roland L Bassett; Patrick Hwu; Kevin B Kim
Pelvic computed tomography scans for surveillance in patients with primary melanoma in the head and neck.
Melanoma research 2011;21(2):127-30.
2011: Agop Bedikian; R C DeConti; R Conry; S Agarwala; Nicholas Papadopoulos; K B Kim; M Ernstoff
Phase 3 study of docosahexaenoic acid-paclitaxel versus dacarbazine in patients with metastatic malignant melanoma.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2011;22(4):787-93.
2011: Judy Ahrar; Sanjay Gupta; Joe Ensor; Kamran Ahrar; David C Madoff; Michael J Wallace; Ravi Murthy; Alda Tam; Patrick Hwu; Agop Bedikian
Response, survival, and prognostic factors after hepatic arterial chemoembolization in patients with liver metastases from cutaneous melanoma.
Cancer investigation 2011;29(1):49-55.
2010: Jade Homsi; Agop Bedikian; Nicholas E Papadopoulos; Kevin B Kim; Wen-Jen Hwu; Sandy L Mahoney; Patrick Hwu
Phase 2 open-label study of weekly docosahexaenoic acid-paclitaxel in patients with metastatic uveal melanoma.
Melanoma research 2010;20(6):507-10.
2010: Wen-Jen Hwu; Robert D Knight; Madhavi Patnana; Roland Bassett; Nicholas E Papadopoulos; Kevin B Kim; Patrick Hwu; Agop Bedikian
Phase I safety study of lenalidomide and dacarbazine in patients with metastatic melanoma previously untreated with systemic chemotherapy.
Melanoma research 2010;20(6):501-6.
2010: Apostolia-Maria Tsimberidou; Siqing Fu; Chaan Ng; Jo Ann Lim; Sijin Wen; David Hong; Jennifer Wheler; Agop Bedikian; Cathy Eng; Michael Wallace; Luis H Camacho; Razelle Kurzrock
A phase 1 study of hepatic arterial infusion of oxaliplatin in combination with systemic 5-fluorouracil, leucovorin, and bevacizumab in patients with advanced solid tumors metastatic to the liver.
Cancer 2010;116(17):4086-94.
2010: Michelle D Williams; Bita Esmaeli; Aydin Soheili; Ronit Simantov; Dan S Gombos; Agop Bedikian; Patrick Hwu
GPNMB expression in uveal melanoma: a potential for targeted therapy.
Melanoma research 2010;20(3):184-90.
2010: Agop Bedikian; Jon Richards; Dmitri Kharkevitch; Michael B Atkins; Eric Whitman; Rene Gonzalez
A phase 2 study of high-dose Allovectin-7 in patients with advanced metastatic melanoma.
Melanoma research 2010;20(3):218-26.
2010: Peter Hersey; Jeffrey Sosman; Steven O'Day; Jon Richards; Agop Bedikian; Rene Gonzalez; WILLIAM SHARFMAN; Robert Weber; Theodore Logan; Manuela Buzoianu; Luz D Hammershaimb; John M Kirkwood
A randomized phase 2 study of etaracizumab, a monoclonal antibody against integrin alpha(v)beta(3), + or - dacarbazine in patients with stage IV metastatic melanoma.
Cancer 2010;116(6):1526-34.
2010: Chan Yoon; Nicholas E Papadopoulos; Luis H Camacho; Susan McIntyre; Gladys C Alvarado; Agop Bedikian; Patrick Hwu; Kevin B Kim
The clinical efficacy of combination of docetaxel and temozolomide in previously treated patients with stage IV melanoma.
Melanoma research 2010;20(1):43-7.
2009: Nicholas E Papadopoulos; Sigrid Ring; Wen-Jen Hwu; Kevin B Kim; Agop Bedikian; Donna L Gerber; Jade Homsi; Patrick Hwu
Phase I/II study of a cisplatin-taxol-dacarbazine regimen in metastatic melanoma.
American journal of clinical oncology 2009;32(5):509-14.
2009: Jade Homsi; Agop Bedikian; Kevin B Kim; Nicholas E Papadopoulos; Wen-Jen Hwu; Sandy L Mahoney; Patrick Hwu
Phase 2 open-label study of weekly docosahexaenoic acid-paclitaxel in cutaneous and mucosal metastatic melanoma patients.
Melanoma research 2009;19(4):238-42.
2009: Agop Bedikian; Nicholas E Papadopoulos; Kevin B Kim; Wen-Jen Hwu; Jade Homsi; Michelle R Glass; Suzanne Cain; Patrick Rudewicz; Laurent Vernillet; Patrick Hwu
A phase IB trial of intravenous INO-1001 plus oral temozolomide in subjects with unresectable stage-III or IV melanoma.
Cancer investigation 2009;27(7):756-63.
2009: Kevin B Kim; Sewa S Legha; Rene Gonzalez; Clay M Anderson; Marcella M Johnson; Ping Liu; Nicholas E Papadopoulos; Omar Eton; Carl Plager; Antonio C Buzaid; Victor G Prieto; Wen-Jen Hwu; Angela M Frost; Gladys Alvarado; Patrick Hwu; Merrick I Ross; jeffrey gershenwald; Jeffrey E Lee; Paul F Mansfield; Robert S Benjamin; Agop Bedikian
A randomized phase III trial of biochemotherapy versus interferon-alpha-2b for adjuvant therapy in patients at high risk for melanoma recurrence.
Melanoma research 2009;19(1):42-9.
2008: Agop Bedikian; Nicholas E Papadopoulos; Kevin B Kim; Anna Vardeleon; Teresa Smith; Biao Lu; Steven R Deitcher
A pilot study with vincristine sulfate liposome infusion in patients with metastatic melanoma.
Melanoma research 2008;18(6):400-4.
2008: Holly L Bartell; Agop Bedikian; Nicholas E Papadopoulos; Tina K Dett; Matthew T Ballo; Jeffrey N Myers; Patrick Hwu; Kevin B Kim
Biochemotherapy in patients with advanced head and neck mucosal melanoma.
Head & neck 2008;30(12):1592-8.
2008: Kevin B Kim; Omar Eton; Darren W Davis; M L Frazier; David J McConkey; A Hafeez Diwan; Nicholas E Papadopoulos; Agop Bedikian; L H Camacho; M I Ross; J N Cormier; jeffrey gershenwald; J E Lee; P F Mansfield; L A Billings; C S Ng; C Charnsangavej; Menashe Bar-Eli; Marcella M Johnson; A J Murgo; Victor G Prieto
Phase II trial of imatinib mesylate in patients with metastatic melanoma.
British journal of cancer 2008;99(5):734-40.
2008: Agop Bedikian; Marcella M Johnson; Carla L Warneke; Nicholas E Papadopoulos; Kevin Kim; Wen-Jen Hwu; Susan McIntyre; Patrick Hwu
Prognostic factors that determine the long-term survival of patients with unresectable metastatic melanoma.
Cancer investigation 2008;26(6):624-33.
2008: Agop Bedikian; Michele Del Vecchio
Allovectin-7 therapy in metastatic melanoma.
Expert opinion on biological therapy 2008;8(6):839-44.
2008: Agop Bedikian; Marcella M Johnson; Carla L Warneke; Susan McIntyre; Nicholas Papadopoulos; Wen-Jen Hwu; Kevin Kim; Patrick Hwu
Systemic therapy for unresectable metastatic melanoma: impact of biochemotherapy on long-term survival.
Journal of immunotoxicology 2008;5(2):201-7.
2006: Agop Bedikian; Michael Millward; Hubert Pehamberger; Robert Conry; Martin Gore; Uwe Trefzer; Anna C Pavlick; Ronald C DeConti; Evan M Hersh; Peter Hersey; John M Kirkwood; Frank G Haluska
Bcl-2 antisense (oblimersen sodium) plus dacarbazine in patients with advanced melanoma: the Oblimersen Melanoma Study Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(29):4738-45.
2006: Patrick Hwu; Agop Bedikian; Elizabeth A Grimm
Challenges of chemosensitivity testing.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(18):5258-9.
2006: Agop Bedikian; Anna Vardeleon; Teresa Smith; Susan Campbell; Rostam Namdari
Pharmacokinetics and urinary excretion of vincristine sulfate liposomes injection in metastatic melanoma patients.
Journal of clinical pharmacology 2006;46(7):727-37.
2006: Agop Bedikian
Metastatic uveal melanoma therapy: current options.
International ophthalmology clinics 2006;46(1):151-66.
2005: Kevin B Kim; Agop Bedikian; Luis H Camacho; Nicholas E Papadopoulos; Cecilia McCullough
A phase II trial of arsenic trioxide in patients with metastatic melanoma.
Cancer 2005;104(8):1687-92.
2004: Helen Gogas; Dimitrios Bafaloukos; Agop Bedikian
The role of taxanes in the treatment of metastatic melanoma.
Melanoma research 2004;14(5):415-20.
2004: Kevin B Kim; Omar Eton; Mary Jo East; Cynthia Hodges; Nicholas E Papadopoulos; Elizabeth A Grimm; Agop Bedikian
Pilot study of high-dose, concurrent biochemotherapy for advanced melanoma.
Cancer 2004;101(3):596-603.
2004: Kevin B Kim; Angela M Sanguino; Cynthia Hodges; Nicholas E Papadopoulos; Omar Eton; Luis H Camacho; Lyle D Broemeling; Marcella M Johnson; Matthew T. Ballo; Merrick I Ross; jeffrey gershenwald; Jeffrey E Lee; Paul F Mansfield; Victor G Prieto; Agop Bedikian
Biochemotherapy in patients with metastatic anorectal mucosal melanoma.
Cancer 2004;100(7):1478-83.
2004: Agop Bedikian; Carl Plager; Nicholas Papadopoulos; Omar Eton; Julie A Ellerhorst; Theresa Smith
Phase II evaluation of paclitaxel by short intravenous infusion in metastatic melanoma.
Melanoma research 2004;14(1):63-6.
2003: Agop Bedikian; Nicholas Papadopoulos; Carl Plager; Omar Eton; Sigrid E Ring
Phase II evaluation of temozolomide in metastatic choroidal melanoma.
Melanoma research 2003;13(3):303-6.
2002: Matthew T. Ballo; jeffrey gershenwald; Gunar K Zagars; Jeffrey E Lee; Paul F Mansfield; Eric A Strom; Agop Bedikian; Kevin B Kim; Nicholas E Papadopoulos; Victor G Prieto; Merrick I Ross
Sphincter-sparing local excision and adjuvant radiation for anal-rectal melanoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(23):4555-8.
2002: Omar Eton; Michael G Rosenblum; Sewa S Legha; Wehei Zhang; Mary Jo East; Agop Bedikian; Nicholas Papadopoulos; Antonio C Buzaid; Robert S Benjamin
Phase I trial of subcutaneous recombinant human interleukin-2 in patients with metastatic melanoma.
Cancer 2002;95(1):127-34.
2002: Nuhad K Ibrahim; Neil Desai; Sewa S Legha; Patrick Soon-Shiong; Richard L Theriault; Edgardo Rivera; Bita Esmaeli; Sigrid E Ring; Agop Bedikian; Gabriel N Hortobagyi; Julie A Ellerhorst
Phase I and pharmacokinetic study of ABI-007, a Cremophor-free, protein-stabilized, nanoparticle formulation of paclitaxel.
Clinical cancer research : an official journal of the American Association for Cancer Research 2002;8(5):1038-44.
2002: Omar Eton; Sewa S Legha; Agop Bedikian; J Jack Lee; Antonio C Buzaid; Cynthia Hodges; Sigrid E Ring; Nicholas E Papadopoulos; Carl Plager; Mary Jo East; Fenghuang Zhan; Robert S Benjamin
Sequential biochemotherapy versus chemotherapy for metastatic melanoma: results from a phase III randomized trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(8):2045-52.
2002: Matthew T. Ballo; Eric A Strom; Gunar K Zagars; Agop Bedikian; Victor G Prieto; Paul F Mansfield; Jeffrey E Lee; jeffrey gershenwald; Merrick I Ross
Adjuvant irradiation for axillary metastases from malignant melanoma.
International journal of radiation oncology, biology, physics 2002;52(4):964-72.
2002: Julie A Ellerhorst; Agop Bedikian; Teresa M Smith; Nicholas E Papadopoulos; Carl Plager; Omar Eton
Phase II trial of 9-nitrocamptothecin (RFS 2000) for patients with metastatic cutaneous or uveal melanoma.
Anti-cancer drugs 2002;13(2):169-72.
2001: Agop Bedikian; Carl Plager; Jubilee R Stewart; Catherine A O'Brian; S K Herdman; Merrick Ross; Nicholas Papadopoulos; Omar Eton; Julie A Ellerhorst; Theresa Smith
Phase II evaluation of bryostatin-1 in metastatic melanoma.
Melanoma research 2001;11(2):183-8.
2000: Agop Bedikian; Carl Plager; Nicholas Papadopoulos; Julie A Ellerhorst; Theresa Smith; Robert S Benjamin
A phase II evaluation of bexarotene (Targretin) capsules in patients with metastatic melanoma.
Oncology reports 2000;7(4):883-6.
2000: Omar Eton; Antonio C Buzaid; Agop Bedikian; T M Smith; Nicholas E Papadopoulos; Julie A Ellerhorst; J L Hibberts; Sewa S Legha; Robert S Benjamin
A phase II study of "decrescendo" interleukin-2 plus interferon-alpha-2a in patients with progressive metastatic melanoma after chemotherapy.
Cancer 2000;88(7):1703-9.
1999: Ewald Wöll; Agop Bedikian; Sewa S Legha
Uveal melanoma: natural history and treatment options for metastatic disease.
Melanoma research 1999;9(6):575-81.
1999: Omar Eton; Mary Jo East; Sewa S Legha; Agop Bedikian; Antonio C Buzaid; Nicholas Papadopoulos; Cynthia Hodges; MA Gianan; C H Carrasco; Robert S Benjamin
Pilot study of intra-arterial cisplatin and intravenous vinblastine and dacarbazine in patients with melanoma in-transit metastases.
Melanoma research 1999;9(5):483-9.
1999: Agop Bedikian; Sewa S Legha; Omar Eton; Antonio C Buzaid; Nicholas Papadopoulos; Carl Plager; S McIntyre; J Viallet
Phase II trial of escalated dose of tirapazamine combined with cisplatin in advanced malignant melanoma.
Anti-cancer drugs 1999;10(8):735-9.
1999: Julie A Ellerhorst; Agop Bedikian; Sigrid E Ring; Antonio C Buzaid; Omar Eton; Sewa S Legha
Phase II trial of doxil for patients with metastatic melanoma refractory to frontline therapy.
Oncology reports 1999;6(5):1097-9.
1998: Antonio C Buzaid; M Colome; Agop Bedikian; Omar Eton; Sewa S Legha; Nicholas Papadopoulos; Carl Plager; Merrick Ross; Jeffrey E Lee; Paul Mansfield; J Rice; Sigrid E Ring; J J Lee; E Strom; Robert Benjamin
Phase II study of neoadjuvant concurrent biochemotherapy in melanoma patients with local-regional metastases.
Melanoma research 1998;8(6):549-56.
1998: Thomas C Prager; Judianne Kellaway; Y Zou; Richard G Urso; S McIntyre; Agop Bedikian
Evaluation of ocular safety: tirapazamine plus cisplatin in patients with metastatic melanomas.
Anti-cancer drugs 1998;9(6):515-24.
1998: Sewa S Legha; Sigrid E Ring; Omar Eton; Agop Bedikian; Antonio C Buzaid; Carl Plager; Nicholas Papadopoulos
Development of a biochemotherapy regimen with concurrent administration of cisplatin, vinblastine, dacarbazine, interferon alfa, and interleukin-2 for patients with metastatic melanoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(5):1752-9.
1998: C M Anderson; Antonio C Buzaid; J Sussman; J Jack Lee; Francis Ali-Osman; Paul Braunschweiger; Carl Plager; Agop Bedikian; Nicholas Papadopoulos; Omar Eton; Sewa S Legha; Elizabeth A Grimm
Nitric oxide and neopterin levels and clinical response in stage III melanoma patients receiving concurrent biochemotherapy.
Melanoma research 1998;8(2):149-55.
1998: Antonio C Buzaid; Francis Ali-Osman; N Akande; Elizabeth A Grimm; J Jack Lee; Agop Bedikian; Omar Eton; Nicholas Papadopoulos; Carl Plager; Sewa S Legha; Robert S Benjamin
DNA damage in peripheral blood mononuclear cells correlates with response to biochemotherapy in melanoma.
Melanoma research 1998;8(2):145-8.
1998: Omar Eton; D D Kharkevitch; MA Gianan; Merrick I Ross; K Itoh; Michael William Pride; Cherrie Donawho; Antonio C Buzaid; Paul F Mansfield; Jeffrey E Lee; Sewa S Legha; Carl Plager; Nicholas E Papadopoulos; Agop Bedikian; Robert S Benjamin; Charles M Balch
Active immunotherapy with ultraviolet B-irradiated autologous whole melanoma cells plus DETOX in patients with metastatic melanoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 1998;4(3):619-27.
1998: Omar Eton; Sewa S Legha; Thomas E Moon; Antonio C Buzaid; Nicholas E Papadopoulos; Carl Plager; A M Burgess; Agop Bedikian; Sigrid E Ring; Qiong Dong; Armand B. Glassman; Charles M Balch; Robert S Benjamin
Prognostic factors for survival of patients treated systemically for disseminated melanoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(3):1103-11.
1997: Sewa S Legha; Sigrid E Ring; Omar Eton; Agop Bedikian; Carl Plager; Nicholas Papadopoulos
Development and results of biochemotherapy in metastatic melanoma: the University of Texas M.D. Anderson Cancer Center experience.
The cancer journal from Scientific American 1997;3 Suppl 1():S9-15.
1997: Agop Bedikian; Sewa S Legha; Omar Eton; Antonio C Buzaid; Nicholas Papadopoulos; S Coates; T Simmons; J Neefe; R von Roemeling
Phase II trial of tirapazamine combined with cisplatin in chemotherapy of advanced malignant melanoma.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1997;8(4):363-7.
1997: Antonio C Buzaid; Merrick I Ross; Charles M Balch; Seng-Jaw Soong; William H McCarthy; L Tinoco; Paul Mansfield; Jeffrey E Lee; Agop Bedikian; Omar Eton; Carl Plager; Nicholas Papadopoulos; Sewa S Legha; Robert S Benjamin
Critical analysis of the current American Joint Committee on Cancer staging system for cutaneous melanoma and proposal of a new staging system.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(3):1039-51.
1996: Sewa S Legha; Sigrid E Ring; Agop Bedikian; Carl Plager; Omar Eton; Antonio C Buzaid; Nicholas Papadopoulos
Treatment of metastatic melanoma with combined chemotherapy containing cisplatin, vinblastine and dacarbazine (CVD) and biotherapy using interleukin-2 and interferon-alpha.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1996;7(8):827-35.
1995: Agop Bedikian; G R Weiss; Sewa S Legha; Howard A Burris; John R Eckardt; J Jenkins; Omar Eton; Antonio C Buzaid; Leslie Ann Smetzer; Daniel Von Hoff
Phase II trial of docetaxel in patients with advanced cutaneous malignant melanoma previously untreated with chemotherapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1995;13(12):2895-9.
1995: Agop Bedikian; Sewa S Legha; G Mavligit; C H Carrasco; S Khorana; Carl Plager; Nicholas Papadopoulos; Robert S Benjamin
Treatment of uveal melanoma metastatic to the liver: a review of the M. D. Anderson Cancer Center experience and prognostic factors.
Cancer 1995;76(9):1665-70.
1994: Antonio C Buzaid; Elizabeth A Grimm; Francis Ali-Osman; Sigrid E Ring; Omar Eton; Nicholas E Papadopoulos; Agop Bedikian; Carl Plager; Sewa S Legha; R Benjamin
Mechanism of the anti-tumour effect of biochemotherapy in melanoma: preliminary results.
Melanoma research 1994;4(5):327-30.